Imunon, Inc.
IMNN • NASDAQ
Imunon, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Stacy R. Lindborg, with a market cap of $9.2M.
CEOStacy R. Lindborg
Next Earnings
Upcoming earnings announcement for Imunon, Inc.
Date
Monday, May 11, 2026 (in a month)
Timing
Before Market Open (8:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$1.02
Earnings History
Past 11 earnings reports for Imunon, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Nov 13, 2025 | Q3 2025 | -$1.16Est: -$1.79 | +35.2% | - | — |  10-Q |
| Aug 5, 2025 | Q2 2025 | -$2.15Est: -$4.41 | +51.2% | - | — | 10-Q |
| May 12, 2025 | Q1 2025 | -$0.28Est: -$0.36 | +22.2% | - | — | 10-Q |
| Feb 27, 2025 | Q4 2024 | -$0.23Est: -$0.36 | +36.1% | - | — | 10-K |
| Nov 7, 2024 | Q3 2024 | -$0.34Est: -$0.40 | +15.0% | - | — | 10-Q |
| Aug 14, 2024 | Q2 2024 | -$0.51Est: -$0.60 | +15.0% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.52Est: -$0.57 | +8.8% | - | — | 10-Q |
| Mar 28, 2024 | Q4 2023 | -$0.52Est: -$2.30 | +77.4% | - | — | 10-K |
| Nov 14, 2023 | Q3 2023 | -$0.37Est: -$0.66 | +43.9% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.61Est: -$0.70 | +12.9% | - | — | 10-Q |
| May 11, 2023 | Q1 2023 | -$0.68Est: -$0.65 | -4.6% | - | — | 10-Q |